Switch to:
GuruFocus has detected 2 Warning Signs with Valeant Pharmaceuticals International Inc $VRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Capital Expenditure
$-391 Mil (TTM As of Mar. 2017)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Valeant Pharmaceuticals International Inc's cash flow for capital expenditures for the three months ended in Mar. 2017 was $-169 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2017 was $-391 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Valeant Pharmaceuticals International Inc Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2017 was -69.6 (Jun. 2016 ) + -90.6 (Sep. 2016 ) + -61.8 (Dec. 2016 ) + -169 (Mar. 2017 ) = $-391 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow_CPEX -35-22-7-101-386-181-185-471-303-291

Valeant Pharmaceuticals International Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow_CPEX -154-115-56-51-81-69-70-91-62-169
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK